Skip to main content
. 2022 Jul 9;11(7):927. doi: 10.3390/antibiotics11070927

Table 6.

Final multivariable generalized linear mixed models with binomial outcomes of wildtype/non-wildtype of Escherichia coli isolates. Amoxiclav and ampicillin non-wildtype tested against the use of penicillins; tetracycline non-wildtype tested against the use of tetracyclines.

Amoxiclav Non-Wildtype Ampicillin Non-Wildtype Tetracycline Non-Wildtype
Weaning Growth Weaning Growth Weaning Growth
Intercept
Estimate
(Std Error)
3.63 (0.45) 2.66 (0.46) 1.20 (0.23) 0.18 (0.27) 0.99 (0.18) −1.34 (0.39)
Random effects
(Std Dev)
Farm 2 × 10−7 0.94 0.59 0.39 0.26 0.29
Feed producer 0.00 0.00 0.00 0.32 0.00 0.25
Short-term antibiotic use p-value - - - - - 0.013
0 (reference) 1
Estimate (Std Error) 2.48 (0.92)
OR [CI95%] 11.94 [1.78;89.28]
Long-term antibiotic use p-value - - - - - -

Weaning: bacterial sampling in June 2018, antibiotic use short-term, 16 April–30 June. Growth: bacterial sampling in October 2018, antibiotic use short-term, 1 July–26 October. Long-term antibiotic use: from 2016 up until sampling. Amoxiclav: amoxicillin in combination with clavulanic acid (1:2). 1 No use of antibiotics has been used as reference: non-significant predictors not included in the final model.